神州控股(00861.HK)擬5億元出售神州數碼醫療14.05%權益
格隆匯1月15日丨神州控股(00861.HK)公佈,2020年1月14日,公司擬以人民幣5億元出售公司間接非全資附屬公司北京勵致維欣的全部股權,該公司進而持有神州數碼醫療的3272.06萬股股份,佔神州數碼醫療全部已發行股本的約14.05%,預期就出售事項確認除税前收益約3.45億港元,所得款項將用於對大數據技術的進一步投資以及能夠提高股東回報的其他選擇。
神州數碼醫療為一家於中國註冊成立的有限公司,主要從事醫療衞生信息化服務、醫療大數據、醫療雲服務。
緊隨出售事項完成後,集團將保留神州數碼醫療約5.99%的全部已發行股份,及神州數碼醫療將不再為公司的聯營公司。集團亦將不再擁有北京勵致維欣的任何股權,而北京勵致維欣將不再為公司的附屬公司。
董事會認為,為了更好地優化產業佈局,圍繞核心技術與融合場景,實現附屬子公司緊密協同併為集團公司全面賦能,出售神州數碼醫療部分股權乃集團變現其於神州數碼醫療大部分投資以獲得溢利的良機,並藉此優化在健康醫療大數據領域佈局為以自主創新的"軟體互聯網"為核心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.